Your Health and Fitness Partner: Androxal & FitHub

We are also excited to expand our scope by including valuable information on Androxal, a potent medication beneficial in various medical conditions. This remarkable drug, derived from the testosterone molecule, has made its mark significantly in the field of endocrinology. Patients and medical professionals can rely on our comprehensive, unbiased, and scientifically grounded content on Androxal for gaining a robust understanding of its uses, side effects, and the latest studies related to it. We understand the necessity of accurate information when it comes to medication. Our newly launched section dedicated to Androxal aims at not only educating the readers about its nuances but also at contributing beneficially to their wellbeing. Stay tuned for insightful articles unraveling the potential of Androxal in medical science.

Sitemap | Policies | Feedback    
 About the Journal
Editorial Board
Journal Subscription
Instructions for Authors
E-mail Alerts
Forthcoming Events
Advertise with Us
Contact Us
 
Article Options
FULL TEXT
ABSTRACT
PDF
Printer Friendly Version
Search Pubmed for
Search Google Scholar for
Article Statistics
Bookmark and Share
 
The Obesity Transition and Non-Alcoholic Fatty Liver Disease: A Glimpse from the Hospital based Study in South India
 
Shabana Abdul Jabbar1, Sudharsanan Sundaramurthi1, Subathra Adithan2, Swaroop 
Kumar Sahu3, Abdoul Hamide4, Vishnu Prasad NR1
1Unit III-HPB Surgery, Department of Surgery, 2Department of Radiology, 3Department of Preventive and Social Medicine, 4Department of Medicine, JIPMER, Pondicherry-605006, India.


Corresponding Author
:
Dr Vishnu Prasad NR
Email: vprasad285@gmail.com


Abstract

Background: NAFLD is one of the most common indications for liver transplantation in the Western population. The studies in India have been conducted in the general population. The present study is the first in India to be conducted in the medical community.
Objective: To assess the prevalence of NAFLD among nursing staff in our institute and to assess the association of NAFLD with its risk factors. 
Materials and Methods: The study was an institute based cross-sectional analytical study conducted among the nursing staff of our institute. A pretested interview was used to collect the participants’ demographic details and personal and medical history. This was followed by measurement of blood pressure, weight, height and, waist circumference, and blood investigation for fasting blood sugar, fasting lipid profile, serum AST, ALT, HBsAg and anti-HCV. The staff underwent ultrasound abdomen to look for presence of fatty liver. 
Results: About 150 nursing staffs were included with a mean age of 34.2 years. The prevalence of NAFLD was 28.7 %. Of the subjects, 54% had obesity, 40.7% had abdominal obesity, 9.3% had diabetes, 3.3% had hypertension, 46.7% had dyslipidemia and 18% had metabolic syndrome. The prevalence of NAFLD was seen to be significantly higher among subjects with these risk factors: age > 40 years, obesity, abdominal obesity, dyslipidemia and metabolic syndrome.
Conclusion: The prevalence of NAFLD among nursing staff is higher than the national prevalence. The risk factors for NAFLD in the studied population were age > 40 years, obesity, abdominal obesity, dyslipidemia and metabolic syndrome.